首页> 外文期刊>Journal of hepato-biliary-pancreatic sciences >Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial
【24h】

Do pancrelipase delayed-release capsules have a protective role against nonalcoholic fatty liver disease after pancreatoduodenectomy in patients with pancreatic cancer? A randomized controlled trial

机译:胰腺癌患者胰十二指肠切除术后胰脂肪酶缓释胶囊对非酒精性脂肪肝有保护作用吗?随机对照试验

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundThe aim of this randomized controlled trial (RCT) was to investigate whether pancrelipase protects against nonalcoholic fatty liver disease (NAFLD) development after pancreatoduodenectomy in patients with pancreatic cancer better than conventional pancreatic enzyme supplementation.
机译:背景这项随机对照试验(RCT)的目的是研究胰腺癌患者胰腺十二指肠切除术后胰脂肪酶是否能预防非酒精性脂肪肝(NAFLD)的发展,优于传统的胰酶补充剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号